These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27366213)

  • 1. Low-dose azathioprine is effective in maintaining remission in steroid-dependent ulcerative colitis: results from a territory-wide Chinese population-based IBD registry.
    Shi HY; Chan FK; Leung WK; Li MK; Leung CM; Sze SF; Ching JY; Lo FH; Tsang SW; Shan EH; Mak LY; Lam BC; Hui AJ; Chow WH; Wong MT; Hung IF; Hui YT; Chan YK; Chan KH; Loo CK; Ng CK; Lao WC; Harbord M; Wu JC; Sung JJ; Ng SC
    Therap Adv Gastroenterol; 2016 Jul; 9(4):449-56. PubMed ID: 27366213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early onset steroid-dependent ulcerative colitis is a predictor of azathioprine response: a longitudinal 12-month follow-up study.
    Chebli LA; Felga GG; Chaves LD; Pimentel FF; Guerra DM; Gaburri PD; Zanini A; Chebli JM
    Med Sci Monit; 2010 Feb; 16(2):PI1-6. PubMed ID: 20110928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis.
    Chebli LA; Chaves LD; Pimentel FF; Guerra DM; Barros RM; Gaburri PD; Zanini A; Chebli JM
    Inflamm Bowel Dis; 2010 Apr; 16(4):613-9. PubMed ID: 19705415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
    Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T
    J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial.
    Kiszka-Kanowitz M; Theede K; Thomsen SB; Bjerrum JT; Brynskov J; Gottschalck IB; Akimenko E; Hilsted KL; Neumann A; Wildt S; Larsen L; Munk JK; Ibsen PH; Janjua HGR; Gluud LL; Mertz-Nielsen A
    EClinicalMedicine; 2022 Mar; 45():101332. PubMed ID: 35274092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine: state of the art in inflammatory bowel disease.
    Sandborn WJ
    Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A retrospective analysis of azathioprine in the treatment of 24 patients with refractory ulcerative colitis].
    Ran WB; Ouyang Q; Dong LF; Xue LY
    Zhonghua Nei Ke Za Zhi; 2012 Aug; 51(8):613-7. PubMed ID: 23158859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term efficacy of azathioprine in steroid-dependent ulcerative colitis.
    Park SK; Yang SK; Ye BD; Kim KJ; Yang DH; Jung KW; Park SH; Kim JW; Byeon JS; Myung SJ; Kim JH
    Scand J Gastroenterol; 2013 Dec; 48(12):1386-93. PubMed ID: 24164382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
    Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.
    Iborra M; Herreras J; Boscá-Watts MM; Cortés X; Trejo G; Cerrillo E; Hervás D; Mínguez M; Beltrán B; Nos P
    Dig Dis Sci; 2019 Jun; 64(6):1612-1621. PubMed ID: 30604371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis.
    Numa K; Kakimoto K; Tanaka Y; Mizuta N; Kinoshita N; Nakazawa K; Koshiba R; Hirata Y; Ota K; Miyazaki T; Nakamura S; Higuchi K; Nishikawa H
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study.
    Mahajan R; Singh A; Kedia S; Kaur K; Midha V; Sahu P; Mehta V; Singh D; Bansal N; Dharni K; Kaushal S; Ahuja V; Sood A
    Intest Res; 2022 Jan; 20(1):64-71. PubMed ID: 33525859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.
    Kim DU; Kim YH; Kim BJ; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC
    Hepatogastroenterology; 2009; 56(94-95):1395-402. PubMed ID: 19950798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: a retrospective multicenter French experience.
    Filippi J; Laharie D; Michiels C; Flamand M; Bouguen G; Nancey S; Presles E; Paul S; Schneider S; Hébuterne X; Roblin X
    J Crohns Colitis; 2015 Mar; 9(3):252-8. PubMed ID: 25588386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
    Gisbert JP; Linares PM; McNicholl AG; Maté J; Gomollón F
    Aliment Pharmacol Ther; 2009 Jul; 30(2):126-37. PubMed ID: 19392869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?
    Campbell S; Ghosh S
    Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1073-6. PubMed ID: 11564958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.